Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus
Open Access
- 1 January 2026
- journal article
- Published by BMJ in Lupus Science & Medicine
- Vol. 13 (1) , e001999
Abstract
Objective: Patients with SLE have increased risk of both clinical cardiovascular disease (CVD) and subclinical atherosclerosis. Reports have shown that controlling CVD risk factors reduces subclinical plaque progression in patients with SLE. We investigated whether this finding was confirmed in our ethnically diverse cohort of patients, measuring total plaque area (TPA) as well as the number of plaques. Methods: 69 patients with SLE underwent ultrasound scans of the carotid and common femoral arterial bifurcations on two occasions (mean 63 months apart). Clinical, demographic, CVD risk and treatment factors were recorded for each patient. Change in plaque number and increase in TPA between scans were the outcome measures. Results: 31 patients had plaque at the second scan. 13 had unchanged number of plaques while 18 had increased plaque numbers including six who were initially free of plaque. All 31 patients had increased TPA with median increase 4.59 mm 2 /year (IQR 2.4–7.33) and these patients were subdivided into two groups with change in TPA above or below the median. Factors associated with both increased plaque number and above-median TPA increase at the second scan compared with the first were age at baseline, positive lupus anticoagulant, negative anti-La and failure to attain at least three CVD risk targets within the follow-up period between scans. We found no associations with disease activity or medication. Conclusion: In this ethnically diverse (40% non-Caucasian) population, we confirmed earlier findings that better control of CVD risk targets reduces progression of atherosclerotic plaque. Anti-La positivity was associated with less plaque progression, which was unexpected.Keywords
Funding Information
- National Institute for Health Research University College London Hospitals Biomedical Research Centre
- European Lupus Society Travelling Fellowship
- Korea National Institute of Health
- Fundação para a Ciência e a Tecnologia (DFA/BD/7131/2020)
- LUPUS UK (1543411)
- Rosetrees Trust and LUPUS UK
This publication has 44 references indexed in Scilit:
- Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10‐Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS RemissionArthritis & Rheumatology, 2025
- Relation of Carotid Intima-Media Thickness and Plaque With Incident Cardiovascular Events in Women With Systemic Lupus ErythematosusThe American Journal of Cardiology, 2013
- Use of atorvastatin in systemic lupus erythematosus in children and adolescentsArthritis & Rheumatism, 2011
- The role of preventive cardiology in systemic lupus erythematosusCurrent Rheumatology Reports, 2007
- Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosusArthritis & Rheumatism, 2006
- Revised British Isles Lupus Assessment Group 2004 index: A reliable tool for assessment of systemic lupus erythematosus activityArthritis & Rheumatism, 2006
- Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosusArthritis & Rheumatism, 1999
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Risk factors for coronary artery disease in patients with systemic lupus erythematosusThe American Journal of Medicine, 1992
- The bimodal mortality pattern of systemic lupus erythematosusThe American Journal of Medicine, 1976